Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hanlon

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Microbial Cell Factories|June 12, 2015
Human FMO2-based microbial whole-cell catalysts for drug metabolite synthesisMartina Geier, Thorsten Bachler, Steven P Hanlon, et al.
Nature Chemistry|October 22, 2016
Identification of (S)-selective transaminases for the asymmetric synthesis of bulky chiral aminesIoannis V Pavlidis, Martin S Weiß, Maika Genz, et al.
Microbiology (Reading, England)|August 28, 1998
Asymmetric reduction of racemic sulfoxides by dimethyl sulfoxide reductases from Rhodobacter capsulatus, Escherichia coli and Proteus speciesSteven P Hanlon, Daniel L Graham, Philip J Hogan, et al.
Drug Metabolism Reviews|May 21, 1999
Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: an intralaboratory comparisonT Friedberg, M P Pritchard, M Bandera, et al.
Journal of Prosthodontics : Official Journal of the American College of Prosthodontists|July 9, 2023
Application of organoselenium in inhibiting Candida albicans biofilm adhesion on 3D printed denture base materialAhmad Alawadi, Parveez Ahmed AbdulAzees, Chun-Yen Lin, et al.
Lancet (London, England)|June 13, 1987
Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infantsP Hanlon, L Hanlon, V Marsh, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Microbial Cell Factories|June 12, 2015
Human FMO2-based microbial whole-cell catalysts for drug metabolite synthesisMartina Geier, Thorsten Bachler, Steven P Hanlon, et al.
Nature Chemistry|October 22, 2016
Identification of (S)-selective transaminases for the asymmetric synthesis of bulky chiral aminesIoannis V Pavlidis, Martin S Weiß, Maika Genz, et al.
Microbiology (Reading, England)|August 28, 1998
Asymmetric reduction of racemic sulfoxides by dimethyl sulfoxide reductases from Rhodobacter capsulatus, Escherichia coli and Proteus speciesSteven P Hanlon, Daniel L Graham, Philip J Hogan, et al.
Drug Metabolism Reviews|May 21, 1999
Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: an intralaboratory comparisonT Friedberg, M P Pritchard, M Bandera, et al.
Journal of Prosthodontics : Official Journal of the American College of Prosthodontists|July 9, 2023
Application of organoselenium in inhibiting Candida albicans biofilm adhesion on 3D printed denture base materialAhmad Alawadi, Parveez Ahmed AbdulAzees, Chun-Yen Lin, et al.
Lancet (London, England)|June 13, 1987
Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infantsP Hanlon, L Hanlon, V Marsh, et al.
Pageof 11